Updated July 2026 · 9 min read

Vasopressin Physiology in Septic Shock

Part of the ICU Pharmacology Hub — browse every related guide in one place.

Vasopressin is the pressor that behaves unlike any other one you hang: you do not titrate it, it works through a completely different receptor than the catecholamines, and its whole rationale rests on a physiology quirk of sepsis. Understand the biology and the strange fixed-dose orders finally make sense.

The physiology: why sepsis creates a vasopressin deficiency

Vasopressin — also called antidiuretic hormone (ADH) — is made in the hypothalamus and released from the posterior pituitary. Normally it is secreted in response to rising serum osmolality and falling blood volume, and at low physiologic levels it has only a minor role in blood pressure. In the early phase of shock, the pituitary dumps its stored vasopressin and levels spike. But as shock persists over hours, those stores become depleted and synthesis cannot keep pace, so measured vasopressin levels fall to inappropriately low values for the degree of hypotension. This is the "relative vasopressin deficiency" of vasodilatory shock. Replacing it to a near-physiologic level is a fundamentally different idea from pushing ever-higher doses of an adrenergic drug.

V1 vs. V2: the two receptors that matter

In septic shock, the pressure-supporting action you care about is the V1-mediated vasoconstriction. Crucially, this happens completely independently of alpha and beta adrenergic receptors. That matters clinically because catecholamine receptors get downregulated and desensitized in prolonged, acidotic shock — the norepinephrine "stops working" as well. Vasopressin, working through a different receptor entirely, can keep constricting vessels when the adrenergic system is exhausted, and it may work better in an acidic environment where catecholamines lose potency.

Why it is dosed as a fixed add-on, not titrated

This is the single most confusing thing about vasopressin for new ICU nurses, and it flows directly from the physiology. The goal is replacement to a physiologic level, not open-ended escalation. Major guidance (the VASST trial and Surviving Sepsis Campaign) supports adding vasopressin at a fixed dose around 0.03 units/min to norepinephrine when the norepinephrine dose is climbing, both to raise the MAP and to lower the catecholamine requirement.

The catecholamine-sparing logic

The reason teams reach for vasopressin as the second pressor is not just "more pressure." Adding it lets you hold or lower the norepinephrine dose, which is desirable because high catecholamine doses carry their own harms: tachyarrhythmias, increased myocardial oxygen demand, immune and metabolic effects, and worsening of the very receptor desensitization that is undermining your support. A fixed dose of vasopressin that shaves several mcg/min off the norepinephrine can meaningfully reduce that adrenergic burden. This is why vasopressin sits on the second rung of the refractory septic shock vasopressor ladder, typically alongside a hard look at whether the patient needs stress-dose hydrocortisone.

Perfusion and safety: what to monitor

Because vasopressin is a pure, powerful vasoconstrictor with no inotropic or chronotropic lift, its risks are all about squeezing perfusion out of the periphery and the gut:

Give it through a central line whenever possible, and — as with any vasoconstrictor — treat extravasation seriously and know your unit's plan. The perfusion assessment you already do for norepinephrine (distal pulses, cap refill, urine output, mentation, lactate) is exactly the assessment that keeps a vasopressin patient safe.

Why CRNA students should know it cold

On the CRNA path, vasopressin is a key rescue agent for vasoplegia — the profound vasodilation seen after cardiopulmonary bypass, in anaphylaxis, and in patients chronically on ACE inhibitors or ARBs who become refractory to phenylephrine and norepinephrine intraoperatively. The same non-catecholamine, V1-mediated logic you learn at the ICU bedside is precisely why it rescues an OR pressure that will not respond to more adrenergic drug. Understanding the receptor story now means you already grasp one of anesthesia's most important pressor concepts.

Bottom line

Sepsis creates a relative vasopressin deficiency; replacing it via V1 receptors restores tone through a pathway independent of the exhausted adrenergic system. That is why vasopressin is a fixed-dose (≈0.03 units/min) catecholamine-sparing add-on to norepinephrine rather than a titrated agent. Respect its pure vasoconstriction by watching fingers, toes, gut, and lactate, and wean it per protocol.

This article is general educational information for licensed clinicians and students, not medical advice or a substitute for your institution's protocols, pharmacy guidance, or a provider's orders. Always follow facility policy and verify every dose independently.